Zdrowie i gospodarka · 11/05/2026

FDA Requests Stakeholder Notification for AGDUFA Reauthorization Consultation Meetings

The US Food and Drug Administration (FDA) is requesting public stakeholders to notify their intent to participate in consultation meetings on reauthorizing the Animal Generic Drug User Fee Act (AGDUFA), which expires on September 30, 2028. The FDA aims to ensure consistent stakeholder representation in the development of recommendations for the next AGDUFA program.